Sonneveld P - Search Results

1

Increased expression of the breast cancer resistance protein (BCRP) in relapsed or refractory acute myeloid leukemia (AML).

van den Heuvel-Eibrink MM, Wiemer EA, Prins A, Meijerink JP, Vossebeld PJ, van der Holt B, Pieters R, Sonneveld P. van den Heuvel-Eibrink MM, et al. Among authors: sonneveld p. Leukemia. 2002 May;16(5):833-9. doi: 10.1038/sj.leu.2402496. Leukemia. 2002. PMID: 11986944

2

Assays for the analysis of P-glycoprotein in acute myeloid leukemia and CD34 subsets of AML blasts.

Sonneveld P, Wiemer E. Sonneveld P, et al. Leukemia. 1997 Jul;11(7):1160-5. doi: 10.1038/sj.leu.2400680. Leukemia. 1997. PMID: 9205006 Review.

3

MDR 1 expression is an independent prognostic factor for response and survival in de novo acute myeloid leukaemia.

van den Heuvel-Eibrink MM, van der Holt B, te Boekhorst PA, Pieters R, Schoester M, Löwenberg B, Sonneveld P. van den Heuvel-Eibrink MM, et al. Among authors: sonneveld p. Br J Haematol. 1997 Oct;99(1):76-83. doi: 10.1046/j.1365-2141.1997.3343148.x. Br J Haematol. 1997. PMID: 9359506 Free article.

4

Inhibitors of multidrug resistance.

Sonneveld P, Wiemer E. Sonneveld P, et al. Curr Opin Oncol. 1997 Nov;9(6):543-8. doi: 10.1097/00001622-199711000-00009. Curr Opin Oncol. 1997. PMID: 9370075 Review.

5

Drug resistance in multiple myeloma.

Sonneveld P, Lokhorst HM, Vossebeld P. Sonneveld P, et al. Semin Hematol. 1997 Oct;34(4 Suppl 5):34-9. Semin Hematol. 1997. PMID: 9408959 Review.

6

Do P-glycoprotein and major vault protein (MVP/LRP) expression correlate with in vitro daunorubicin resistance in acute myeloid leukemia?

Broxterman HJ, Sonneveld P, Pieters R, Lankelma J, Eekman CA, Loonen AH, Schoester M, Ossenkoppele GJ, Löwenberg B, Pinedo HM, Schuurhuis GJ. Broxterman HJ, et al. Among authors: sonneveld p. Leukemia. 1999 Feb;13(2):258-65. doi: 10.1038/sj.leu.2401331. Leukemia. 1999. PMID: 10025900

7

The prognostic significance of membrane transport-associated multidrug resistance (MDR) proteins in leukemia.

van den Heuvel-Eibrink MM, Sonneveld P, Pieters R. van den Heuvel-Eibrink MM, et al. Among authors: sonneveld p. Int J Clin Pharmacol Ther. 2000 Mar;38(3):94-110. doi: 10.5414/cpp38094. Int J Clin Pharmacol Ther. 2000. PMID: 10739113 Review.

8

MDR1 expression in poor-risk acute myeloid leukemia with partial or complete monosomy 7.

van den Heuvel-Eibrink MM, Wiemer EA, de Boevere MJ, Slater RM, Smit EM, van Noesel MM, van der Holt B, Schoester M, Pieters R, Sonneveld P. van den Heuvel-Eibrink MM, et al. Among authors: sonneveld p. Leukemia. 2001 Mar;15(3):398-405. doi: 10.1038/sj.leu.2402027. Leukemia. 2001. PMID: 11237063

9

Absence of mutations in the deoxycytidine kinase (dCK) gene in patients with relapsed and/or refractory acute myeloid leukemia (AML).

van den Heuvel-Eibrink MM, Wiemer EA, Kuijpers M, Pieters R, Sonneveld P. van den Heuvel-Eibrink MM, et al. Among authors: sonneveld p. Leukemia. 2001 May;15(5):855-6. doi: 10.1038/sj.leu.2402112. Leukemia. 2001. PMID: 11368449 No abstract available.

10

van den Heuvel-Eibrink MM, Wiemer EA, de Boevere MJ, van der Holt B, Vossebeld PJ, Pieters R, Sonneveld P. van den Heuvel-Eibrink MM, et al. Among authors: sonneveld p. Blood. 2001 Jun 1;97(11):3605-11. doi: 10.1182/blood.v97.11.3605. Blood. 2001. PMID: 11369657 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

629 results

Search Page

Filters